Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal tract microbiota modulation refers to the intentional alteration—through dietary changes, supplementation with specific microorganisms like probiotics/prebiotics, fecal transplants, phage therapy, or other targeted interventions—of the complex community structure and function formed by trillions of microorganisms inhabiting the human digestive tract. This ecosystem includes bacteria, archaea, fungi, and viruses that collectively influence digestion/metabolism; shape local and systemic immunity; maintain intestinal barrier integrity; produce key bioactive compounds such as short-chain fatty acids; modulate inflammation; affect neurological processes via the gut-brain axis; and directly interact with drugs through metabolic transformation. Imbalances in this ecosystem (“dysbiosis”) are linked to a wide range of diseases from gastrointestinal disorders like IBD/IBS/CDI to metabolic syndromes and neurodegeneration. Therapeutic strategies aim either at restoring balance after disruption or at shifting the community toward a configuration associated with health benefits. However—as “modulation” is an intervention strategy rather than a discrete molecular entity—it is not considered a canonical therapeutic target like an enzyme/receptor/transporter but rather describes approaches targeting an entire ecological system within the body.[1][2][3][4][6] **Note:** The entry "Gastrointestinal tract microbiota modulation" does not refer to a single molecule/receptor/protein but instead describes an intervention strategy targeting a complex biological system. Therefore it should be marked as **not a canonical target** (`is_target: false`) and **incorrect** for standard molecular target listings (`is_incorrect: true`).
– Restoration or alteration of microbial community composition to a healthier state via introduction or promotion of beneficial microbes[1][2] – Suppression or elimination of pathogenic bacteria using bacteriophages or competitive exclusion by commensals[2] – Enhancement/modulation of host immune responses through microbial metabolites and cell signaling pathways[4]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal tract microbiota modulation.